Evidence map›Paper›PMID 22246185›Full record

ArticleThe EMBO journal2012

Rsk-mediated phosphorylation and 14-3-3ɛ binding of Apaf-1 suppresses cytochrome c-induced apoptosis.

Jiyeon Kim, Amanda B Parrish, Manabu Kurokawa, Kenkyo Matsuura, Christopher D Freel, Joshua L Andersen, Carrie E Johnson, Sally Kornbluth

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Signal transduction in cancer.Cold Spring Harbor perspectives in medicine · 2015
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jiyeon KimDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Amanda B Parrish
Manabu Kurokawa
Kenkyo Matsuura
Christopher D Freel
Joshua L Andersen
Carrie E Johnson
Sally Kornbluth
Duke Medical Center · USDuke University Hospital · US

Funding

Inhibition of Cytochrome c-induced Caspase ActivationR01CA102707 · NCI · DUKE UNIVERSITY · PI KORNBLUTH, SALLY A · 2003 to 2014
$2.6M
Control of caspase activation in apoptosisR01GM080333 · NIGMS · DUKE UNIVERSITY · PI KORNBLUTH, SALLY A · 2007 to 2015
$2.6M
Molecular mechanisms of chemoresistance in breast cancerK99CA140948 · NCI · DUKE UNIVERSITY · PI KUROKAWA, MANABU · 2010 to 2011
$193k
NCI NIH HHS CA 102707NCI NIH HHS K99 CA140948NCI NIH HHS R01 CA102707NIGMS NIH HHS GM080333NIGMS NIH HHS R01 GM080333
6 · The paper itself

Abstract

Many pro-apoptotic signals trigger mitochondrial cytochrome c release, leading to caspase activation and ultimate cellular breakdown. Cell survival pathways, including the mitogen-activated protein kinase (MAPK) cascade, promote cell viability by impeding mitochondrial cytochrome c release and by inhibiting subsequent caspase activation. Here, we describe a mechanism for the inhibition of cytochrome c-induced caspase activation by MAPK signalling, identifying a novel mode of apoptotic regulation exerted through Apaf-1 phosphorylation by the 90-kDa ribosomal S6 kinase (Rsk). Recruitment of 14-3-3ɛ to phosphorylated Ser268 impedes the ability of cytochrome c to nucleate apoptosome formation and activate downstream caspases. High endogenous levels of Rsk in PC3 prostate cancer cells or Rsk activation in other cell types promoted 14-3-3ɛ binding to Apaf-1 and rendered the cells insensitive to cytochrome c, suggesting a potential role for Rsk signalling in apoptotic resistance of prostate cancers and other cancers with elevated Rsk activity. Collectively, these results identify a novel locus of apoptosomal regulation wherein MAPK signalling promotes Rsk-catalysed Apaf-1 phosphorylation and consequent binding of 14-3-3ɛ, resulting in decreased cellular responsiveness to cytochrome c.

Indexed as

Apoptosis14-3-3 ProteinsAmino Acid SequenceAnimalsApoptotic Protease-Activating Factor 1Cell LineChlorocebus aethiopsCytochromes cHumansModels, BiologicalMolecular Sequence DataPhosphorylationProtein BindingRibosomal Protein S6 Kinases14-3-3 ProteinsAPAF1 protein, humanApoptotic Protease-Activating Factor 1Cytochromes cRibosomal Protein S6 KinasesYWHAE protein, human

Identifiers

PMID22246185
PMCPMC3297998
OpenAlexW2128170318

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.